President - Lawrence Kong (Amgen)

Vice President - Hui Harry Wang (Nicholson De Vos Webster & Elliott)

VP of Programming

Ella Zheng(Sanford Heisler)
Lenny Huang (Alston & Bird)

Program Co-Chairs - Sherry Liu (Rimon P.C.)

Treasurer

Randy Wu (10X Genomics)
Sean Li (Quinn Emanuel)

Secretary - Chen Ye (Jones Day)

Social Co-Chairs

Rick Weber (Oracle)
Vivian Lei (Oracle)

Public Relations/Bloggers - Sherry Liu (Rimon P.C.)

Web Designers

John Cao (Womble Bond Dickinson)
Kevin G. Shao (Womble Bond Dickinson)

In-house Committee Chair/Strategic Advisor - Lawrence Kong (Amgen)

In-house Committee Social Chair - Andrew Tam (Rocket Fuel)

Program Coordinators

Adam Li (Jun He)
Athena Zhou (Engie-GCN)
Bowen Liu (Sheppard Mullin)
Ella Zheng (Sanford Heisler)
Esther Phu (Morgan Lewis)
Linda Yu
Sean Li (Quinn Emanuel)
Stephanie Yang (Jackson Lewis)
Suzette S. Lin (Substantia)

Executive Team Members

Adam Li (Jun He)
Andrew Tam (Rocket Fuel)
Athena Zhou (Engie-GCN)
Bowen Liu (Sheppard Mullin)
Chen Ye (Jones Day)
Ella Zheng (Sanford Heisler)
Esther Phu (Morgan Lewis)
Hui Harry Wang (Nicholson De Vos Webster & Elliott)
Jessie Zhou (UCHastings '18)
John Cao (Womble Bond Dickinson)
Kaylee (Wen) Yang (Baker Botts)
Kevin G. Shao (Womble Bond Dickinson)
Lawrence Kong (Amgen)
Lenny Huang (Alston & Bird)
Linda Yu
Randy Wu (10X Genomics)
Rick Weber (Oracle Corp.)
Sean Li (Quinn Emanuel)
Sherry Liu (Rimon P.C.)
Stephanie Yang (Jackson Lewis)
Suzette S. Lin (Substantia)
Vivian Lei (Oracle)

Recent Past Presidents

Linda Wu (Natera, Inc.) - 2017-2018 bio

Dr. Linda Wu has extensive experience in a wide range of intellectual property (IP) law, including patent prosecution, litigation, Inter Partes Review (IPR), interference, due diligence, freedom to operate, infringement, invalidity, and patentability evaluations.

Before joining Natera in May 2016 as an IP Counsel, Linda was an associate attorney with Foley & Lardner LLP, where her practice focused on IP counseling for pharmaceutical and biotech companies. Linda earned her law degree from Santa Clara University.

Prior to her law career, Linda was a Scientist with Medarex/BMS, where Linda contributed to IND filings with FDA. Linda was a Post-Doctoral Fellow at Stanford University and earned her PhD in Biology/Immunology from University of Toronto – Canada.